Oncotarget

Research Papers:

CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle

Yao Fan, Haiping Li, Xiaolong Liang and Zheng Xiang _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:19934-19946. https://doi.org/10.18632/oncotarget.15253

Metrics: PDF 1744 views  |   HTML 2706 views  |   ?  


Abstract

Yao Fan1,2, Haiping Li1,2, Xiaolong Liang1,2, Zheng Xiang1,2

1Chongqing Key Laboratory of Department of General Surgery, Chongqing Medical University, Chongqing, China

2Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Correspondence to:

Zheng Xiang, email: [email protected]

Keywords: colon cancer, CBX3, CDK6, p21, proliferation

Received: August 01, 2016     Accepted: December 12, 2016     Published: February 10, 2017

ABSTRACT

Heterochromatin protein 1γ (CBX3) links histone methylation marks to transcriptional silence, DNA repair and RNA splicing, but a role for CBX3 in cancer remains largely unknown. In this study, we show that CBX3 in colon cancer cells promotes the progression of the cell cycle and proliferation in vitro and in vivo. Cell cycle (G1 phase to S phase) related gene CDK6 and p21 were further identified as targets of CBX3. In addition, we found that enhancing CDK6 suppresses cell proliferation by upregulating inhibitor p21 in the absence of CBX3, and this function is independent of the kinase activity of CDK6. Our results demonstrate a key role of CBX3 in colon carcinogenesis via suppressing the expression of CDK6/p21, which may disrupt the role of CDK6 in transcriptionally regulating p21, as part of a negative feedback loop to limit CDK6 excessive activation.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15253